RESEARCH PAPER
Paget disease of bone among hospitalized patients in Poland
 
More details
Hide details
1
Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland
2
National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
3
Witold Chodźko Institute of Rural Health in Lublin, Poland
 
Ann Agric Environ Med. 2018;25(1):182–185
KEYWORDS:
TOPICS:
ABSTRACT:
Introduction:
Paget’s disease (PDB) is a focal disorder of bone remodeling that occurs commonly in older people with decreasing prevalence reported in European countries. This disease is most often asymptomatic, but it can cause a variety of medical complications resulting in considerable morbidity and reduced quality of life. There is little information regarding the epidemiology of PDB in Poland. To the best of the authors’ knowledge, this is the first large epidemiological analysis of this disease in Poland.

Objective:
The aim of this study was to analyze factors that may be related to the PDB epidemiology among hospitalized patients in Poland.

Material and methods:
The analysis was conducted on the basis of population-based administrative data, taken from a Polish hospital morbidity study carried out by the National Institute of Public Health between January 2008 – December 2014.

Results:
Analyzed data covered 662 hospitalization records. The final study sample comprised 94 (41.8%) male and 131 (58.2%) female patients with first-time hospitalizations for PDB, with a significant predominance of females (P<0.02), and the predominance of patients living in urban (73%) than in rural areas (27%), P<0.001. The average age of the sample was 56.8 years (CI: 54.3–59.3; SD 18.8; range 1–93 years). The number of PDB cases hospitalized in Poland significantly decreased during the analyzed period of time.

Conclusions:
PDB is a rare disease with decreasing trends observed among hospitalized patients in Poland. The study results may suggest the existence of environmental risk factors for the development of PDB.

CORRESPONDING AUTHOR:
Krzysztof Kanecki   
Department of Social Medicine and Public Health. Medical University of Warsaw., Oczki 3, 02-007 Warszawa, Poland
 
REFERENCES (42):
1. van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C. Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res. 2002; 17(3): 465–471.
2. Gold DT, Boisture J, Shipp KM, Pieper CF, Lyles KW. Paget’s disease of bone and quality of life. J Bone Miner Res. 1996; 11(12): 1897–1904.
3. Tan A, Ralston SH. Clinical presentation of Paget’s disease: evaluation of a contemporary cohort and systematic review. Calcif Tissue Int. 2014; 95(5): 385–392.
4. Doyle T, Gunn J, Anderson G, Gill M, Cundy T. Paget’s disease in New Zealand: evidence for declining prevalence. Bone. 2002; 31(5): 616–619.
5. Selby PL. Guidelines for the diagnosis and management of Paget’s disease: a UK perspective. J Bone Miner Res. 2006; 21 Suppl 2: 92–93.
6. Takata S, Hashimoto J, Nakatsuka K, Yoshimura N, Yoh K, Ohno I, et al. Guidelines for diagnosis and management of Paget’s disease of bone in Japan. J Bone Metab. 2006; 24(5): 359–367.
7. Whyte MP. Clinical practice. Paget’s disease of bone. N Engl J Med. 2006; 355(6): 593–600.
8. Devogelaer JP, Bergmann P, Body JJ, Boutsen Y, Goemaere S, Kaufman JM, et al. Management of patients with Paget’s disease: a consensus document of the Belgian Bone Club. Osteoporos Int: 2008; 19(8):1109–1117.
9. Langston AL, Campbell MK, Fraser WD, MacLennan GS, Selby PL, Ralston SH. Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget’s disease of bone. J Bone Miner Res. 2010; 25(1): 20–31.
10. Lecuyer N, Grados F, Dargent-Molina P, Deramond H, Meunier PJ, Fardellone P. Prevalence of Paget’s disease of bone and spinal hemangioma in French women older than 75 years: data from the EPIDOS study. Joint Bone Spine. 2000; 67(4): 315–318.
11. Gennari L, Merlotti D, Martini G, Nuti R. Paget’s disease of bone in Italy. J Bone Miner Res. 2006; 21 Suppl 2: 14–21.
12. Guanabens N, Garrido J, Gobbo M, Piga AM, del Pino J, Torrijos A, et al. Prevalence of Paget’s disease of bone in Spain. Bone. 2008; 43(6): 1006–1009.
13. Reis RL, Poncell MF, Diniz ET, Bandeira F. Epidemiology of Paget’s disease of bone in the city of Recife, Brazil. Rheumatol Int. 2012; 32(10): 3087–3091.
14. Altman RD, Bloch DA, Hochberg MC, Murphy WA. Prevalence of pelvic Paget’s disease of bone in the United States. J Bone Miner Res. 2000; 15(3): 461–465.
15. Hashimoto J, Ohno I, Nakatsuka K, Yoshimura N, Takata S, Zamma M, et al. Prevalence and clinical features of Paget’s disease of bone in Japan. J Bone Miner Metab. 2006; 24(3): 186–190.
16. Sirikulchayanonta V, Jaovisidha S, Subhadrabandhu T, Rajatanavin R. Asymptomatic Paget’s bone disease in ethnic Thais: a series of four case reports and a review of the literature. J Bone Miner Metab. 2012; 30(4): 485–492.
17. Wat WZ, Cheung WS, Lau TW. A case series of Paget’s disease of bone in Chinese. Hong Kong Med J. 2013; 19(3): 242–248.
18. Cundy T, Rutland MD, Naot D, Bolland M. Evolution of Paget’s disease of bone in adults inheriting SQSTM1 mutations. Clin Endocrinol. 2015; 83(3): 315–319.
19. Chung PY, Van Hul W. Paget’s disease of bone: evidence for complex pathogenetic interactions. Semin Arthritis Rheum. 2012; 41(5): 619–641.
20. Bolland MJ, Cundy T. Republished: Paget’s disease of bone: clinical review and update. Postgrad Med J. 2014; 90(1064): 328–331.
21. Poor G, Donath J, Fornet B, Cooper C. Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res. 2006; 21(10): 1545–1549.
22. Tiegs RD, Lohse CM, Wollan PC, Melton LJ. Long-term trends in the incidence of Paget’s disease of bone. Bone. 2000; 27(3): 423–427.
23. Gennari L, Di Stefano M, Merlotti D, Giordano N, Martini G, Tamone C, et al. Prevalence of Paget’s disease of bone in Italy. J Bone Miner Res. 2005; 20(10): 1845–1850.
24. Eekhoff ME, van der Klift M, Kroon HM, Cooper C, Hofman A, Pols HA, et al. Paget’s disease of bone in The Netherlands: a population-based radiological and biochemical survey--the Rotterdam Study. J Bone Miner Res. 2004; 19(4): 566–570.
25. Bastin S, Bird H, Gamble G, Cundy T. Paget’s disease of bone--becoming a rarity? Rheumatology (Oxford). 2009; 48(10): 1232–1235.
26. Gennari L, Merlotti D, Martini G, Nuti R. Paget’s Disease of Bone in Italy. J Bone Miner Res. 2006; 21(S2): 14–21.
27. Audet MC, Jean S, Beaudoin C, Guay-Belanger S, Dumont J, Brown JP, et al. Environmental factors associated with familial or non-familial forms of Paget’s disease of bone. Joint Bone Spine. 2016 Dec 6. DOI: 10.1016/j.jbspin.2016.11.010. [Epub ahead of print].
28. Pusch CM, Czarnetzki A. Archaeology and prevalence of Paget’s disease. J Bine Miner Res. 2005; 20(8):1484; author reply 1485. Epub 2005 May 2.
29. Cundy T. Is Paget’s disease of bone disappearing? Skeletal Radiol. 2006; 35(6): 350–351.
30. Cooper C, Schafheutle K, Dennison E, Kellingray S, Guyer P, Barker D. The epidemiology of Paget’s disease in Britain: is the prevalence decreasing? J Bone Miner Res. 1999; 14(2): 192–197.
31. Corral-Gudino L, Garcia-Aparicio J, Sanchez-Gonzalez MD, Miron-Canelo JA, Blanco JF, Ralston SH, et al. Secular changes in Paget’s disease: contrasting changes in the number of new referrals and in disease severity in two neighboring regions of Spain. Osteoporos Int. 2013; 24(2): 443–450.
32. Central Statistical Office of Poland. Available from: http://stat.gov.pl/ [Accessed: 2016–11–13].
33. Abramson JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiologic perspectives & innovations: EP+I. 2011; 8(1): 1.
34. Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ, Melton LJ, 3rd. Morbidity and mortality associated with Paget’s disease of bone: a population-based study. J Bone Miner Res. 2008; 23(6): 819–825.
35. Cundy HR, Gamble G, Wattie D, Rutland M, Cundy T. Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int. 2004; 75(5): 358–364.
36. Cooper C, Harvey NC, Dennison EM, van Staa TP. Update on the epidemiology of Paget’s disease of bone. J Bone Miner Res. 2006; 21 Suppl 2: 3–8.
37. Corral-Gudino L, Borao-Cengotita-Bengoa M, Del Pino-Montes J, Ralston S. Epidemiology of Paget’s disease of bone: a systematic review and meta-analysis of secular changes. Bone. 2013; 55(2): 347–352.
38. Lopez-Abente G, Morales-Piga A, Bachiller-Corral FJ, Illera-Martin O, Martin-Domenech R, Abraira V. Identification of possible areas of high prevalence of Paget’s disease of bone in Spain. Clin Exp Rheumatol. 2003; 21(5): 635–638.
39. Merlotti D, Gennari L, Galli B, Martini G, Calabro A, De Paola V, et al. Characteristics and familial aggregation of Paget’s disease of bone in Italy. J Bone Miner Res. 2005; 20(8): 1356–1364.
40. Gennari L, Gianfrancesco F, Di Stefano M, Rendina D, Merlotti D, Esposito T, et al. SQSTM1 gene analysis and gene-environment interaction in Paget’s disease of bone. J Bone Miner Res. 2010; 25(6): 1375–1384.
41. Singer FR. Paget’s disease of bone-genetic and environmental factors. Nat Rev Endocrinol. 2015; 11(11): 662–671.
42. Matthews BG, Afzal MA, Minor PD, Bava U, Callon KE, Pitto RP, et al. Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget’s disease. J Clin Endocrinol Metab. 2008; 93(4): 1398–1401.
eISSN:1898-2263
ISSN:1232-1966